Peripheral Myeloid-Derived Suppressor Cells are good biomarkers of the efficacy of Fingolimod in Multiple Sclerosis
C. Camacho-Toledano, I. Machin-Diaz, L. Calahorra, M. Cabanas, D. Otaegui, T. Castillo-Trivino, L. M. Villar, L. Costa-Frossard, M. Comabella, L. Midaglia, J. M. Garcia-Dominguez, J. Garcia-Arocha, M. C. Ortega, D. Clemente
This study shows that baseline levels of monocytic-MDSCs predict fingolimod efficacy in MS patients and EAE mice.
bioRxiv · Aug 22, 2022Immunology